StoneX Group’s Biogen BIIB Stock Holding History

StoneX Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,362	Closed	-$278K	–	575
2022 Q2	$278K	Buy	+1,362	New	+$278K	0.03%	440
2017 Q3	–	Sell	-4,489	Closed	-$1.22M	–	191
2017 Q2	$1.22M	Buy	+4,489	New	+$1.19M	0.38%	85

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

StoneX Group's BIIB Position: Q3 2022 in Review

StoneX Group sold out of Biogen (BIIB) in Q3 2022, closing a stake of 1,362 shares — an estimated $278K sold.

StoneX Group first reported a position in BIIB in Q2 2017 and held it in 2 quarters. The position peaked at $1.22M in Q2 2017. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

StoneX Group reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
StoneX Group sold 1,362 Biogen shares in Q3 2022, an estimated $278K.
StoneX Group first reported a position in Biogen in Q2 2017 and held it in 2 quarters.
StoneX Group's Biogen position peaked at $1.22M in Q2 2017.
985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on StoneX Group's 13F filing for Q3 2022, filed 8 Nov 2022.